LLP-3

LLP-3 is a potent Survivin inhibitor that disrupts the Survivin-Ran interaction in cancer cells. LLP-3 can be used in the research of Glioblastoma multiforme (GBM) [1].

Product Specifications

CAS Number

[1453835-43-2]

UNSPSC

12352005

Target

Survivin

Type

Reference compound

Related Pathways

Apoptosis

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/llp-3.html

Solubility

10 mM in DMSO

Smiles

N#CC1=C(C2=CC(OCC3=CC=CC=C3)=CC(OCC4=CC=CC=C4)=C2)C=C(C5=CC(Cl)=CC=C5O)NC1=O

Molecular Formula

C32H23ClN2O4

Molecular Weight

534.99

References & Citations

[1]Hacer Guvenc, et al. Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex. Clin Cancer Res. 2013 Feb 1;19 (3) :631-42.